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Introduction: The present study was designed to examine whether methylene chloride (CH2Cl2) fraction extracted
from Rubus coreanum affects the contractility of the isolated thoracic aortic strips and blood pressure of
normotensive rats.
Methods: One of the common carotid arteries or of the femoral arteries was catheterized with a polyethylene
tubing. The tubing was connected to a pressure transducer, and pulse of the mean arterial blood pressure was
recorded on a biological polygraph continuously.
Results: The CH2Cl2 fraction (range, 200 to 800 μg/mL) significantly depressed both phenylephrine (PE, 10 μM)- and
high K+ (56 mM)-induced contractile responses of the isolated thoracic aortic strips in a concentration-dependent
fashion. In the simultaneous presence of Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME) (an inhibitor of nitric
oxide [NO] synthase, 300 μM) and the CH2Cl2 fraction (400 μg/mL), both PE- and high K+-induced contractile responses
were recovered to the significant level of the corresponding control response in comparison with inhibition of CH2Cl2
fraction treatment alone. Moreover, in the simultaneous presence of the CH2Cl2 fraction after pretreatment with 0.4%
CHAPS (3-[(3-cholamidopropyl) dimethylammonio]-1-propane sulfonate), both PE- and high K+-induced contractile
responses were recovered to the significant level of the corresponding control response compared to the inhibitory
response of CH2Cl2 fraction treatment alone. Also, in anesthetized rats, the CH2Cl2 fraction (range, 0.3 to 3.0 mg/kg)
injected into a femoral vein dose-dependently produced depressor responses. This hypotensive action of the CH2Cl2
fraction was greatly inhibited after treatment with phentolamine (1 mg/kg), chlorisondamine (1 mg/kg), L-NAME
(3 mg/kg/30 min), or sodium nitroprusside (30 μg/kg/30 min). Intravenous infusion of the CH2Cl2 fraction (range, 1.0 to
10.0 mg/kg/30 min) markedly inhibited norepinephrine-induced pressor responses.
Discussion: Taken together, these results demonstrate that the CH2Cl2 fraction causes vascular relaxation in the
isolated rat thoracic aortic strips as well as hypotensive action in anesthetized rats. These vasorelaxation and
hypotension of the CH2Cl2 fraction seem to be mediated at least by the increased NO production through the
activation of NO synthase of the vascular endothelium and the inhibitory adrenergic modulation.
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Previously, it has been reported that polyphenol compounds
isolated from Rubus coreanum MIQUEL (PCRC) inhibit the
secretory responses of catecholamines (CA) evoked by the
stimulation of cholinergic (both muscarinic and nicotinic)
receptors as well as by direct membrane depolarization from
the isolated perfused adrenal gland of normotensive rats [1]
and spontaneously hypertensive rats [2]. It seems that this
inhibitory effect of PCRC is exerted by inhibiting both the
Ca2+ influx into the rat adrenal medullary chromaffin cells
and the uptake of Ca2+ into the cytoplasmic calcium store
partly through the increased nitric oxide (NO) production
due to the activation of NO synthase [1,2].
Polyphenols also act on other targets involved in the
metabolism of mammalian cells, including NO, which by
itself regulates hemostasis [3], thrombus development
[4], and vascular tone [5,6]. The properties of NO may
therefore explain, at least in part, the beneficial effects of
plant polyphenols. Several authors have reported that
extracts from grapes and wine induce endothelium-
dependent relaxation via enhanced generation and/or in-
creased biological activity of NO leading to the elevation
of cyclic guanosine monophosphate (cGMP) levels [7].
The critical step for the activation of NO synthase in
endothelial cells is the increase in Ca2+ concentration
leading to the production of NO and the subsequent
endothelium-dependent vasorelaxation [8]. The bio-
logical activity of NO can be effectively increased by the
scavengers of oxygen free radicals [9].
As aforementioned, there are many reports about the
effects of red wine on the cardiovascular system. Despite
these studies, there are so far few reports on in vitro
functional effects of fractions isolated from Bokboonja
wine on the cardiovascular system. Therefore, the aim of
the present study was to investigate the effects of some
fractions isolated from Bokboonja wine on blood pres-
sure and on the contractility of the isolated rat thoracic
aorta and to clarify their mechanism of action in order




All procedures involving animal experiment were ap-
proved by the Committee of Experimental Animals,
Chosun University School of Medicine.
Vasorelaxation
Mature male Sprague-Dawley rats (purchased from
DAMOOL SCIENCE; International Customer Service,
Seoul, Korea), weighing 200 to 300 g, were used in the
experiment. The animals were housed individually in
separate cages, and food (Cheil Animal Chow, Seoul,
Korea) and tap water were allowed ad libitum for atleast a week to adapt to experimental circumstances.
On the day of the experiment, a rat was anesthetized
with thiopental sodium (50 mg/kg) intraperitoneally
and tied in supine position on a fixing panel.
(1). Isolation of thoracic aortic strips: The thorax was
opened by a midline incision, and the heart and
surrounding area were exposed by placing three hook
retractors. The heart and a portion of the lung were
not removed but pushed over to the right side and
covered by saline-soaked gauze pads in order to ob-
tain enough working space for isolating the thoracic
aortic vessel. The aorta was isolated from the prox-
imal part of the heart to the vicinity of the liver and
immediately immersed in cold Krebs solution. The
blood within the aorta was rapidly removed. The aorta
was cut into the ring of 4-to 5-mm length.
(2). Recording of mechanical activity: The ring segment
of the aorta was mounted in a muscle bath by sliding
the ring over two parallel stainless steel hooks (0.15
mm in diameter). The lower hook was fixed at the
bottom of the bath and the upper was connected to
an isometric transducer (Grass FT. 03). The signal
from the transducer was displayed on a polygraph
(Grass Instruments Model 79; Grass Instrument Co.,
Quincy, MA, USA). The volume of the bath was 25
mL and the bath solution was saturated with 95% O2
and 5% CO2 at 37°C. The composition (mM) of
Krebs was as follows: NaCl, 118.4; KCl, 4.7; CaCl2,
2.5; MgCl2, 1.18; NaHCO3, 25; KH2PO4, 1.2; and
glucose, 11.7. The final pH of the solution was
maintained at 7.4 to 7.5. During equilibration period
of 2 h, the resting tension was adjusted to 0.5 g.
After the equilibration period, the ring was
challenged with 35 mM KCl twice, and if it
responded with contraction, the proper experiment
was started. Vasoconstrictors were administered into
the bath in order to obtain dose-response curves. In
the subsequent experiments, under the presence of
extracts of Rubus coreanum, some vasoconstrictors
were administered, respectively. The data were
expressed as percentage of the control tension.
(3). Removal of endothelium: A solution containing
0.4% 3-[(3-cholamidopropyl) dimethylammonio]-
1-propane sulfonate (CHAPS) was perfused for 30
s to remove the endothelium [10], followed by
washout with a drug-free solution. The effect of
CHAPS was confirmed by the absence of a flow in-
crease due to 10−6 M acetylcholine and the pres-
ence of a response to 10−6 M sodium nitroprusside
before the experiments were started. The
vasoconstrictor-induced response of non-treated
(control) and CHAPS-treated preparations was
compared in parallel.
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(1). Preparation for measurement of arterial pressure:
The animal was tied in supine position on a fixing
panel to insert a T-formed cannula into the trachea
for securing free air passage. The rectal temperature
was maintained at 37°C to 38°C by a thermostatic-
ally controlling blanket and heating lamp through-
out the course of the experiment.
(2). Measurement of blood pressure: In order to
observe the change of arterial pressure, one of the
common carotid arteries or of the femoral arteries
was catheterized with a polyethylene tubing
(outside diameter [od], 0.5 mm). The tubing was
connected to a pressure transducer (Gould Co.,
Quincy, MA, USA), and pulse of the mean arterial
blood pressure was recorded on a biological
polygraph continuously (Grass Co.). The chart
speed was adjusted to 2 cm/min. The artery tubing
was filled with heparin solution (400 IU) to prevent
the blood coagulation during the experiment.
Another cannulation with a polyethylene tubing
(od, 0.3 mm) was made into a femoral vein for the
administration of drugs and supplemental
anesthetic agents as needed to maintain light
surgical anesthesia. Each rat was left undisturbed
for at least 30 min after completion of the operative
procedures to permit cardiovascular parameters to
be stabilized, and drugs under investigation were
administered at intervals of 60 min.
Fractionation of Rubus coreanum
Fractionation of Rubus coreanum extract was made from a
1-year-old wine brewed from Rubus coreanum MIQUEL at
the Research Institute of Bokboonja, Gochang County,
Cheollabukdo Province, Korea, as shown in Figure 1A: wine
of Rubus coreanum was concentrated in a vacuum. And
then, it was extracted with methylene chloride (CH2Cl2)
followed by extraction with ethylacetate (EtOAc) and N-
butanol. These fractions were concentrated by vacuum,
evaporated and atomized, and lyophilized by freeze dryer
(Coldvac-80; Hanil R&D, Seoul, Korea). Extract of 2.095 g
CH2Cl2, 10.968 g EtOAc, and 9.057 g N-butanol was ob-
tained from 6 L Bokboonja wine, respectively. The working
solution of these extracts was prepared by dissolving in
0.9% NaCl solution or dimethyl sulfoxide (DMSO) on the
day of each experiment and filtered before administration
and diluted appropriately with Krebs-bicarbonate solution
(final concentration of alcohol was less than 0.1%).
Statistical analysis
The statistical difference between the control and the
pretreated groups was determined by the Student t test
and analysis of variance test. A p value of less than 0.05was considered to represent statistically significant changes
unless specifically noted in the text. Values given in the text
refer to means and the standard errors of the mean. The
statistical analysis of the experimental results was made by a
computer program described by Tallarida and Murray [11].
Drugs and their sources
The following drugs were used: phenylephrine (PE) hydro-
chloride, potassium chloride, Nω-nitro-L-arginine methyl
ester hydrochloride (L-NAME), CHAPS, norepinephrine
bitartrate (Sigma-Aldrich Chemical Co., St. Louis, MO,
USA), chlorisondamine chloride, phentolamine mesylate
(Ciba Pharmaceutical Co., Summit, NJ, USA), thiopental
sodium, and heparin sodium (Daehan Choongwae Pharm.
Co., Seoul, Korea). Drugs were dissolved in distilled water
(stock) and added to the normal Krebs solution as required
except the CH2Cl2 fraction, which were dissolved in DMSO
and diluted appropriately with Krebs-bicarbonate solution
(final concentration of DMSO was less than 0.1%). Concen-
trations of all drugs except the CH2Cl2 fraction used were
expressed in terms of molar base.
Results
Effects of four fractions extracted from Rubus coreanum
on PE-induced contractile responses in the thoracic aortic
strips of normotensive rats
The effects of four fractions extracted from Rubus coreanum
on PE-induced contractile responses in the rat aorta with an
intact endothelium were examined. In the present study, the
CH2Cl2 fraction itself did not produce any effect on the rest-
ing tension in the aortic strips with an intact endothelium
isolated from rats (data not shown). In a previous study, it
has been found that PCRC causes vascular relaxation in the
isolated aortic strips of spontaneously hypertensive rats
(SHRs) at least partly by the increased NO production
through the activation of NO synthase of the vascular endo-
thelium, but not through the activation of cyclooxygenase
[12]. Therefore, it was attempted to examine the effects of
four fractions (EtOAc, CH2Cl2, N-butanol [BuOH], and
water [H2O]) isolated from Rubus coreanum M. on PE-
induced contractile responses in the isolated rat aortic strips.
As shown in Figure 1B, in the presence of the CH2Cl2 frac-
tion (400 μg/mL), EtOAc fraction (400 μg/mL), BuOH frac-
tion (400 μg/mL), and H2O fraction (400 μg/mL) 5 min
before addition of PE, the contractile responses of PE
(10−5 M) were significantly reduced to 50% ± 1% (p < 0.01,
n = 6), 58% ± 11% (p < 0.01, n = 6), 90% ± 18% (p < 0.01,
n = 8), and 78% ± 2% (p < 0.05, n = 6) of the corresponding
control response (1.6 ± 0.1 g), respectively. Based on these
results, for the PE-induced contractile response, the follow-
ing rank order of inhibitory potency was obtained: CH2Cl2
fraction > EtOAc fraction >H2O fraction > BuOH fraction.
Therefore, in all subsequent experiments, the CH2Cl2 frac-
tion (400 μg/mL) only was used.
Figure 1 (A) Fractionation procedure of Rubus coreanum and (B) comparative effects of four fractions (water [H2O], butanol [BuOH],
ethylacetate [EtOAc], and methylene chloride [CH2Cl2]) extracted from Rubus coreanum on the inhibition of phenylephrine (PE)-induced
contractile responses in the isolated thoracic aortic strips of rats. The contractile responses were induced by adding 10 μM PE at a 120-min
interval after adaptation with normal Krebs solution for 2 h prior to initiation of the experimental protocol. Each column denotes active tension induced
evoked by 10 μM PE before and after adding fractions (400 μg/mL) of EtOAc, CH2Cl2, BuOH, and H2O, respectively. Vertical bars represent the standard
error of the mean. Ordinate: the active tension (% of control, 1.6 ± 0.1 g [10 μM]). Abscissa: after treatment of each fraction. Statistical difference was
obtained by comparing its control with each fraction-pretreated group. *p < 0.05. **p < 0.01.
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coreanum on contractile responses induced by PE and
high K+ in the thoracic aortic strips of normotensive rats
PE is a selective agonist of adrenergic α1-receptors, which
exhibits vasoconstriction. To establish the inhibitory effect
of the CH2Cl2 fraction on PE (10
−5 M)-induced contractile
responses, in the presence of the CH2Cl2 fraction at 400 μg/
mL 5 min before addition of PE, the contractile response ofFigure 2 (A) Influence of methylene chloride (CH2Cl2) fraction on phe
responses and (B) the typical tracing showing the effect of CH2Cl2 fra
response in the isolated rat aortic strips. Black column and brick column
after adding 400 μg/mL of CH2Cl2 fraction, respectively. Other methods are
response (control); right: PE-induced contractile response in the presence o
(control); right: KCl-induced contractile response in the presence of CH2Cl2
(10 μM) and KCl (56 mM) were added into the bath, respectively. The chartPE (10−5 M) was greatly reduced to 50% ± 5% (p < 0.01,
n = 6) of the corresponding control response (1.8 ± 0.2 g)
(Figure 2).
High K+ exerts two distinct effects on cells: (1)
depolarization of the cell membrane and (2) depolarization-
induced influx of calcium via voltage-dependent calcium
channels [13]. When added to the bath, high potassium at
5.6 × 10−2 M, which is a membrane-depolarizing agent,nylephrine (PE)- and high potassium (KCl)-induced contractile
ction on PE- and high potassium (KCl)-induced contractile
denote active tension induced evoked by 10 μM PE before and
the same as in Figure 1. **p < 0.01. (A) Left: PE-induced contractile
f CH2Cl2 fraction (400 μg/mL). (B) Left: KCl-induced contractile response
fraction (400 μg/mL). At arrow marks, the indicated doses of PE
speed was 5 mm/min.
Yu et al. Clinical Hypertension 2014, 20:6 Page 6 of 14
http://www.clinicalhypertension.com/content/20/1/6caused an increase in aortic contraction (2.4 ± 0.2 g). As
shown in Figure 2, high potassium (5.6 × 10−2 M)-induced
contractile response after preloading with 400 μg/mL of
the CH2Cl2 fraction 5 min before high potassium was sig-
nificantly reduced to 62% ± 8% (p < 0.01, n = 6) of the cor-
responding control response (2.4 ± 0.2 g).
Influence of the CH2Cl2 fraction plus L-NAME on the con-
tractile responses evoked by PE and high potassium in
the thoracic aortic strips of normotensive rats
In a previous study, it has been demonstrated that PCRC
inhibits the CA secretion evoked by cholinergic stimulation
and direct membrane depolarization from the perfused rat
adrenal medulla, which was blocked in the presence of L-
NAME, a NO synthase inhibitor [2]. These results suggest
that PCRC can inhibit the CA release at least partly
through the activation of NO synthase in the rat adrenal
medulla. Therefore, in the presence of L-NAME, it was
likely interesting to compare the effects of the CH2Cl2 frac-
tion on the contractile responses induced by high potas-
sium and PE.
In the simultaneous presence of CH2Cl2 fraction
(400 μg/mL) and L-NAME (300 μM), the aortic con-
tractile response evoked by PE (10−5 M) was recovered
to 94% ± 11% (p < 0.05, n = 10) of the control in com-
parison with the inhibitory response of CH2Cl2 fraction
treatment alone (50% ± 5%) from the resting tension
level as shown in Figure 3. High potassium (5.6 × 10−2 M)-
induced contractile response in the simultaneous presence
of CH2Cl2 fraction (400 μg/mL) and L-NAME (300 μM)
was recovered to 54% ± 4% (p < 0.05, n = 6) of the corre-
sponding control compared with the inhibitory response of
CH2Cl2 fraction treatment alone (38% ± 4%) from the rest-
ing tension level (Figure 3).
Influence of the CH2Cl2 fraction plus CHAPS on contractile
responses induced by PE and high potassium in the
thoracic aortic strips of normotensive rats
As shown in Figure 3, CH2Cl2 fraction-induced vasore-
laxation was markedly blocked in the presence of L-
NAME, a NO synthase inhibitor. Therefore, it is likely
interesting to examine the effects of CHAPS, a detergent
which suppresses endothelial function [10], on CH2Cl2
fraction-induced inhibitory responses to the contractile
active tension evoked by high potassium and PE.
In the presence of the CH2Cl2 fraction (400 μg/mL)
after pretreatment with 0.4% CHAPS, the aortic con-
tractile response evoked by PE (10−5 M) was recovered
to 67% ± 13% (p < 0.01, n = 6) of the corresponding
control compared with the inhibitory response of
CH2Cl2 fraction treatment alone (38% ± 4%) from the
resting tension level, as shown in Figure 4. High potassium
(5.6 × 10−2 M)-induced contractile response in the simul-
taneous presence of the CH2Cl2 fraction (400 μg/mL) afterpretreatment with CHAPS was recovered to 67% ± 13% (p
< 0.01, n = 6) of the corresponding control compared with
the inhibitory response of CH2Cl2 fraction treatment alone
(38% ± 4%) from the resting tension level (Figure 4).
Effects of intravenous CH2Cl2 fraction on blood pressure
in the anesthetized normotensive rats
All rats used in this study were allowed to be stabilized
at least for 60 min before experimental protocols were
initiated. When cardiovascular parameters were stabi-
lized, the CH2Cl2 fraction (range, 0.3 to 3.0 mg/kg) was
given into a femoral vein of the normotensive rats anes-
thetized with thiopental sodium and urethane. The
CH2Cl2 fraction produced a dose-related and potent fall
in arterial blood pressure. However, an equivalent vol-
ume of 0.9% saline given into a femoral vein did not pro-
duce any changes in blood pressure of the normotensive
rats. As shown in Figure 5, intravenous 0.3 mg of
CH2Cl2 fraction induced a fall in mean arterial pressure
by 9.1 ± 1.1 mm Hg from the original baseline of 122.2 ±
4.0 mm Hg, but increasing doses of the CH2Cl2 fraction
to 1.0 and 3.0 mg/kg intravenously (i.v.) showed decreased
mean arterial pressures of 15.0 ± 1.8 and 25.3 ± 2.7 mm
Hg, respectively, from the preinjection level of the baseline
from ten rats. All of the above experimental results were
statistically significant from the corresponding preinjec-
tion values (p < 0.01).
Influence of phentolamine, chlorisondamine, L-NAME, and
sodium nitroprusside on the CH2Cl2 fraction-induced
depressor action
In eight rats, in order to examine the relationship be-
tween adrenergic α-receptors and CH2Cl2 fraction-
induced depressor action, phentolamine (1.0 mg/kg) was
given i.v. after obtaining the control responses of the
intravenous CH2Cl2 fraction. In the presence of a phen-
tolamine effect, depressor response induced by the intra-
venous CH2Cl2 fraction (1.0 mg/kg) was greatly
depressed to −5.8 ± 1.7 mm Hg (p < 0.01) from the pre-
injection level of the baseline as compared with the con-
trol depressor response (−19.1 ± 2.9 mm Hg) as shown
in Figures 6 and 7A. Chlorisondamine (1.0 mg/kg), an
autonomic ganglionic blocking agent, was given slowly
into a femoral vein. Following the administration of
chlorisondamine, the baseline of blood pressure was re-
duced from 119.2 ± 4.1 to 70.2 ± 3.9 mm Hg. In ten rats,
intravenous CH2Cl2 fraction (1.0 mg/kg)-induced de-
pressor response after chlorisondamine treatment was
markedly inhibited by −0.4 ± 0.2 mm Hg (p < 0.01) as
compared with the control depressor response (−19.0 ±
3.3 mm Hg), as shown in Figures 6 and 7B. Intravenous
infusion of L-NAME (3 mg/kg/30 min), an inhibitor of
NO synthase, into a femoral vein resulted in a significant
decrease by −4.7 ± 0.8 mm Hg (p < 0.01, n = 20) in the
Figure 3 (A) Influence of methylene chloride (CH2Cl2) fraction plus N
ω-nitro-L-arginine methyl ester hydrochloride (L-NAME) on the
contractile responses evoked by phenylephrine (PE) and high potassium (KCl) and (B) the typical tracing showing the effect of CH2Cl2
fraction plus L-NAME on (upper panel) PE- and (lower panel) high potassium-induced contractile response in the isolated rat aortic strips.
Statistical difference was obtained by comparing the control with the CH2Cl2 fraction-pretreated group or CH2Cl2 fraction (400 μg/mL) plus L-NAME
(300 μM). Other methods are the same as in Figure 2. *p < 0.05. **p < 0.01. (A) Left: PE-induced contractile response (control); middle: PE-induced
contractile response in the presence of CH2Cl2 fraction (400 μg/mL); right: PE-induced contractile response in the presence of CH2Cl2 fraction
(400 μg/mL) plus L-NAME (300 μM). (B) Left: KCl-induced contractile response (control); middle: KCl-induced contractile response in the presence of
CH2Cl2 fraction (400 μg/mL); right: KCl-induced contractile response in the presence of CH2Cl2 fraction (400 μg/mL) plus L-NAME (300 μM).
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response (−15.4 ± 1.5 mm Hg), as shown in Figures 6
and 8A. In six rats, in order to examine the relationship
between NO and CH2Cl2 fraction-induced depressor ac-
tion, sodium nitroprusside (30 μg/kg/30 min) wasinfused i.v. after obtaining the control responses of the
intravenous CH2Cl2 fraction. In the presence of a so-
dium nitroprusside effect, depressor response induced
by the intravenous CH2Cl2 fraction (1.0 mg/kg) was
greatly depressed to −9.3 ± 3.5 mm Hg (p < 0.01) as
Figure 4 (A) Influence of 3-[(3-cholamidopropyl) dimethylammonio]-1-propane sulfonate (CHAPS) plus methylene chloride (CH2Cl2)
fraction on contractile responses induced by phenylephrine (PE) and high potassium (KCl) and (B) the representative tracing of CHAPS plus
CH2Cl2 fraction effect on contractile responses induced by PE and high potassium in the isolated rat aortic strips. Other methods are the
same as in Figure 3. **p < 0.01. At arrow marks, PE (10 μM) and KCl (56 mM) were added into CHAPS-pretreated aortic strips. (A) PE-induced
contractile response after CH2Cl2 fraction (400 μg/mL) treatment in a CHAPS-pretreated aortic strip. (B) High KCl-induced contractile response
after CH2Cl2 fraction (400 μg/mL) treatment in a CHAPS-pretreated aortic strip. The chart speed was 5 mm/min.
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4.3 mm Hg) as shown in Figures 6 and 8B.
Influence of the intravenous CH2Cl2 fraction on
norepinephrine-evoked pressor responses in the
anesthetized rats
As shown in Figures 2, 6, and 7, the CH2Cl2 fraction
greatly inhibited PE-induced contractile response of the
aortic strip of normotensive rats, and also, CH2Cl2
fraction-induced depressor responses were significantly
reduced by phentolamine and chlorisondamine; this sug-
gests that the CH2Cl2 fraction might cause hypotension
through the blockade of peripheral adrenergic α-receptors. It is also of interest to examine the effect of
the CH2Cl2 fraction on norepinephrine-evoked pressor
responses. When cardiovascular parameters were stabi-
lized for 30 min before the experimental protocols were
initiated, the administration of physiological saline solu-
tion in a volume of 0.2 mL into a femoral vein did not
cause any changes in arterial blood pressure. Then, it
was tried to test the effect of the CH2Cl2 fraction on
norepinephrine-induced hypertensive responses in the
anesthetized rats.
In nine rats, as shown in Figure 9, norepinephrine at
doses of 0.3, 1.0, and 3.0 μg/kg i.v. caused dose-dependent
pressor responses of 8.9 ± 0.8, 16.5 ± 1.7, and 29.6 ± 2.6 mm
Figure 5 (A) Dose-dependent hypotensive effects of methylene chloride (CH2Cl2) fraction and (B) the typical tracings of CH2Cl2
fraction-induced hypotensive action in an anesthetized rat. CH2Cl2 fraction (0.3, 1.0, and 3.0 mg/kg, respectively) was administered into a
femoral vein. Arterial blood pressure from preinjection level was expressed in millimeters of mercury. CH2Cl2 fraction at the indicated doses
(0.3, 1.0, and 3.0 mg/kg) was injected intravenously at the arrow marks.
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ively. After infusion of the CH2Cl2 fraction with a rate of
3.0 mg/kg/30 min, hypertensive responses of norepineph-
rine at doses of 0.3, 1.0, and 3.0 μg/kg were inhibited max-
imally to 4.9 ± 0.6 mm Hg (p < 0.01), 10.8 ± 1.2 mm Hg
(p < 0.01), and 20.3 ± 2.5 mm Hg (p < 0.01) of control re-
sponses at the above same doses, respectively.
Discussion
The present experimental results demonstrate that the
CH2Cl2 fraction causes depressor action as well as vaso-
relaxation in the isolated aortic strips of normotensiverats at least partly by the increased NO production
through the activation of NO synthase of the vascular
endothelium.
In support of this idea, it has been demonstrated that
PCRC inhibits the CA secretory responses evoked by
stimulation of cholinergic (both muscarinic and nicotinic)
receptors as well as by direct membrane depolarization
from the isolated perfused adrenal gland of the normoten-
sive rats [1] and SHRs [14]. It seems that this inhibitory ef-
fect of PCRC is exerted by inhibiting both the Ca2+ influx
into the rat adrenal medullary chromaffin cells and the
uptake of Ca2+ into the cytoplasmic calcium store partly
Figure 6 Influence of phentolamine, chlorisondamine, 3-[(3-cholamidopropyl) dimethylammonio]-1-propane sulfonate (L-NAME), and
nitroprusside on methylene chloride (CH2Cl2) fraction-induced hypotensive action in the anesthetized rats. Phentolamine (1 mg/kg),
chlorisondamine (1 mg/kg), L-NAME (3 mg/kg/30 min), and sodium nitroprusside (30 μg/kg/30 min) were given intravenously (i.v.), respectively,
after obtaining CH2Cl2 fraction-induced hypotensive action. Statistical difference was analyzed by comparing control response with that after
treatment with each blockade. **p < 0.01.
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tion of NO synthase [1,14]. In the present study, the
CH2Cl2 fraction elicited a concentration-dependent inhib-
ition in phenylephrine-induced contractile responses of
rat aortic rings with a functional endothelium. This effect
was greatly abolished in the absence of a functional endo-
thelium by treatment with CHAPS, which is a detergent
for the removal of endothelium, indicating that the vaso-
dilator effect of the CH2Cl2 fraction is dependent on
endothelium-derived relaxing factors. To evaluate the par-
ticipation of NO in the vasorelaxant activity of the CH2Cl2
fraction, aortic rings were also treated with L-NAME, a
classical NO synthase inhibitor. In the present experimental
condition, the CH2Cl2 fraction-induced vasodilatation was
markedly blocked, as similarly observed in endothelium-
denuded aortic rings by CHAPS, suggesting that NO is the
main endothelium-derived relaxing factor involved in
CH2Cl2 fraction activity. The present results are fully in ac-
cordance with previous findings obtained from red winesand grapes. Previously, it has been reported that red wines
and grapes exhibit endothelium-dependent relaxation of
blood vessels via enhanced generation and/or increased
biological activity of NO, leading to the elevation of cGMP
levels [6,7,15,16]. In vivo, the polyphenol compounds of red
wine (PCRW) were shown to reduce blood pressure in
normotensive and hypertensive rats [17-19]. In denuded
aortic rings, a PCRW concentration 103-fold higher was
necessary to induce relaxation [20,21]. Besides NO, red
wine affected the formation of other mediators of vascular
tone, such as endothelium-derived hyperpolarizing factor
[20] and prostacyclin [22]. The mechanisms underlining
NO-dependent vasorelaxation caused by PCRW were in-
vestigated [6,8,23]. In addition to the increased NO syn-
thase activity, PCRW may prolong the half-life and increase
the bioavailability of NO, by reducing its degradation medi-
ated by reactive oxygen species [24]. It has also been shown
that Provinol elicited endothelium-dependent relaxation of
rat femoral artery by the Ca2+-induced increase of NO
Figure 8 A typical tracing showing the effects of (A) Nω-nitro-L-
arginine methyl ester hydrochloride (L-NAME) and (B)
nitroprusside on the hypotensive action of methylene chloride
(CH2Cl2) fraction in the anesthetized rats. L-NAME (3 mg/kg/30 min)
and nitroprusside (30 μg/kg/30 min) were given intravenously after
obtaining control hypotensive responses of CH2Cl2 fraction, respectively.
i.v., intravenously.
Figure 7 A typical tracing showing the effects of (A)
phentolamine and (B) chlorisondamine on the hypotensive
action of methylene chloride (CH2Cl2) fraction in the
anesthetized rats. Phentolamine (1 mg/kg) and chlorisondamine
(1 mg/kg) were given intravenously after obtaining control
hypotensive responses of CH2Cl2 fraction, respectively.
i.v., intravenously.
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[6]. Yu et al. [2] have found that PCRW inhibits the CA
secretory responses evoked by stimulation of cholinergic
(both muscarinic and nicotinic) receptors as well as by dir-
ect membrane depolarization from the isolated perfused
adrenal gland of the normotensive rats. It seems that this
inhibitory effect of PCRW is mediated by blocking the in-
flux of both ions through Na+ and Ca2+ channels into the
rat adrenomedullary chromaffin cells as well as by inhibit-
ing the release of Ca2+ from the cytoplasmic calcium store,
which are due at least partly to the increased NO produc-
tion through the activation of NO synthase.
Generally, endothelium-derived NO plays an important
role in the control of vascular homeostasis. NO modulates
vascular tone and growth of vascular smooth muscle cells
and decreases platelet adhesion and aggregation. It also de-
creases the adherence of other blood components [5,25]. A
decrease in NO production or bioavailability is closely asso-
ciated with endothelial dysfunction or injury, which is an
important factor in pathologies such as atherosclerosis, re-
stenosis, and hypertension [26]. PCRW and a grape skinextract also reduced blood pressure in males in several
models of experimental hypertension [19,27-30], which was
related to a combination of vasodilator and antioxidant
actions. Pechanova and his colleagues [27] also provided
evidence that Provinol partially prevents L-NAME-induced
hypertension, cardiovascular remodeling, and vascular dys-
function via the increase of NO synthase activity and
prevention of oxidative stress. In the present study, the
intravenous CH2Cl2 fraction-induced hypotensive response
was significantly inhibited by pretreatment with L-NAME
or sodium nitroprusside. In light of these results, it seems
that the CH2Cl2 fraction may produce hypotensive action
at least through the increased NO production by eNOS ac-
tivation. Thus, in view of the beneficial effects of plant poly-
phenols, the present results of the CH2Cl2 fraction should
shed light on the fact that the unique components of the
CH2Cl2 fraction may contribute to the treatment or pre-
vention of hypertension through their complex influence
on the NO balance in the cardiovascular system.
Figure 9 (A) Influence of intravenous methylene chloride (CH2Cl2)
fraction on norepinephrine (NE)-evoked pressor responses and (B)
the representative tracing of effect of CH2Cl2 fraction on
intravenous NE-induced pressor responses in anesthetized rats.
CH2Cl2 fraction (3.0 mg/kg/30 min) was given intravenously after
obtaining the corresponding control responses of intravenous NE (0.3,
1.0, and 3.0 μg/kg, respectively). **p < 0.01. At arrow marks, the indicated
doses (0.3, 1.0, and 3.0 μg/kg) of NE were administered into a femoral
vein. (A) NE-induced hypertensive responses in a non-treated rat. (B)
NE-induced hypertensive responses in a CH2Cl2 fraction-pretreated rat.
CH2Cl2 fraction was infused into a femoral vein with a rate of 3 mg/kg/
30 min. Arterial blood pressure from preinjection level was expressed in
-mmHg. The chart speed was 10 mm/min. i.v., intravenously.
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(KCl) opens voltage-dependent calcium channels by de-
polarizing the cell membrane of vascular smooth muscle,resulting in increased influx of extracellular Ca2+ [31-34].
Kim et al. [35] have shown that the contractile responses of
vascular smooth muscle induced by CaCl2 and KCl may re-
sult most likely from the increased influx of extracellular
Ca2+ through the voltage-dependent calcium channels
(VDCCs). VDCCs are activated by depolarization of the
plasma membrane when the extracellular K+ concentration
is increased. In the present work, incubation with the
CH2Cl2 fraction inhibited KCl concentration-dependent
contractile response in rat aortic strips. This result is con-
sistent with the effect of 17-β estradiol on a large elastic
aorta as in previous reports [36,37] and is also supported by
another study [38]. These findings suggest that the CH2Cl2
fraction may have Ca2+ antagonistic properties and can in-
hibit extracellular Ca2+ influx through VDCCs, which are
similar to those of 17-β estradiol or resveratrol. Generally,
the mechanism of potassium-induced vasoconstriction has
been shown to be through the calcium influx by the
opening of the VDCCs [39,40]. VDCC blockers such as
nifedipine or verapamil have been reported to attenuate
potassium-induced vasoconstriction [41,42]. The contract-
ile activity of vascular smooth muscle cells is mainly
regulated by control over the cytoplasmic calcium concen-
tration and both intracellular and extracellular calcium
pools [42,43]. Based on these findings, the present results
that the CH2Cl2 fraction inhibited high K
+-evoked contract-
ile responses and that the inhibitory effect of the CH2Cl2
fraction on high K+-evoked contractile responses was en-
hanced, although their data are not shown here, indicate
that the CH2Cl2 fraction may block the VDCCs in aortic
smooth muscle cells.
In the present study, the finding that CH2Cl2 fraction-
induced hypotension is suppressed by the pretreatment
with an autonomic ganglionic blocker (chlorisondamine)
and adrenergic α-blocker (phentolamine) suggests strongly
that the CH2Cl2 fraction-induced hypotension may be
mediated through the inhibition of sympathetic tone. The
action site of the CH2Cl2 fraction seems to be the sympa-
thetic ganglia a higher level because its hypotensive re-
sponse is inhibited by prior treatment of chlorisondamine.
Furthermore, in terms of the fact that intravenous CH2Cl2
fraction-evoked hypotension is significantly attenuated by
adrenergic α-receptor blockade (phentolamine) and that
the CH2Cl2 fraction inhibits greatly the pressor responses
of norepinephrine, it is considered that the CH2Cl2 fraction
causes the hypotensive action via the blockade of adrener-
gic α1-receptors. Among drugs which interfere with periph-
eral sympathetic function, adrenergic α-receptor blocking
agents alone cause reversal of the epinephrine pressor
response [44]. When epinephrine is administered to un-
treated animals, its α-agonist properties predominate,
resulting in a rise in mean arterial pressure. However, in the
presence of adrenergic α-receptor blockade, the peripheral
β2-agonist properties of epinephrine predominate and a fall
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observed. In contrast, the pressor responses to norepin-
ephrine are impaired by adrenergic α-receptor blockade
but are not reversed [45] as this agent possesses little β2-
agonist activity [46]. These previous facts support that
CH2Cl2 fraction-induced depressor action is due to the
blockade of adrenergic α-receptors in the periphery. In
the present work, the CH2Cl2 fraction also inhibited the
norepinephrine-induced pressor responses as well as PE-
evoked contractile responses in aortic strips isolated from
normotensive rats. These results suggest that the CH2Cl2
fraction may elicit the antagonistic activity of adrenergic
α1-receptors.
Based on all these results, many studies strongly support
the view that a polyphenol-rich diet, such as Rubus corea-
num and red wine, could improve endothelial function and
that the mechanisms of this beneficial effect found in the
above-discussed in vitro studies (especially increased NO)
might be involved in vivo, both in patients and in animals.
Conclusion
In conclusion, the present study provides conclusive data
showing for the first time that the CH2Cl2 fraction elicits
endothelium- and NO-dependent vasorelaxation, which
are due to the unique polyphenolic constituents of the
CH2Cl2 fraction that may augment eNOS activity, and
thus facilitates endothelial NO output, and suggesting
that the CH2Cl2 fraction might be helpful in treating or
alleviating cardiovascular diseases, such as hypertension
and angina pectoris. The identification of the responsible
constituents should help in the design of strategies to
prevent or to improve cardiovascular diseases.
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